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553Poxviruses Aren’t StuPYD
Pathogens utilize many strategies to dampen the host
inflammatory response. In this issue of Immunity, a re-
port by Johnston and colleagues reveals a poxvirus
strategy that inhibits the inflammasome, arresting se-
cretion of interleukin-1-related cytokines, thus silenc-
ing key alarms that mobilize host defenses.
The host-pathogen relationship is complex, and in most
cases a balance exists between host control and path-
ogen escape from immune defenses. The poxviruses in
particular have evolved numerous strategies to inhibit
or dampen the host immune response to infection (Seet
et al., 2003). In their work, Johnston and colleagues de-
scribe the M13L protein that is encoded by a rabbit pox-
virus (myxoma virus) and that blocks the production of
interleukin (IL)-1 family cytokines from infected cells
(Johnston et al., 2005). M13L contains a pyrin domain
(PYD), a member of the ‘‘death-fold’’ family that is com-
posed of six tightly packed a helices to generate a
Greek key fold, which can interact specifically with a cel-
lular PYD-containing protein called ASC-1 (apoptosis-
associated speck-like protein containing a caspase re-
cruitment domain) (Masumoto et al., 1999). ASC-1 is a
component of the ‘‘inflammasome,’’ a multiprotein com-
plex located in the cytosol that is responsible for acti-
vation of proinflammatory caspases (cysteine-based
aspartic acid-specific proteinases, caspase-1, -4, and -5
in humans). Active caspase-1 and/or caspase-5 pro-
teolytically process proIL-1b (and IL-18) to its active
form in the cytosol (Martinon and Tschopp, 2004). John-
ston et al. show that M13L-PYD inhibits the activation of
procaspase-1 and subsequent secretion of IL-1b and
IL-18 from myxoma-infected cells (Johnston et al.,
2005). The authors establish the importance of M13L-
PYD in the course of myxoma infection by using a mu-
tant virus deleted in the PYD domain of the M13L gene.
This mutant virus caused a limited infection that failed to
spread from the initial site of inoculation, demonstrating
that the M13L protein contributes to the virulence in this
host and underscoring the importance of the IL-1 family
in mounting effective defenses.
Tight regulation of the production of proinflammatory
cytokines is required to maintain the homeostasis of
host tissues. Insufficient control of IL-1 production
through deregulation of the inflammasome can lead toinflamed tissues and organ damage. There are several
types of these autoinflammatory diseases in humans
(e.g., Muckle-Wells syndrome, familial cold urticaria,
and familial Mediterranean fever) where mutations in
key components of the inflammasome are thought to
contribute to disease (Martinon and Tschopp, 2004).
NALP3 promotes inflammasome assembly and is fre-
quently mutated in its NACHT/NOD domain, leading
to increased ‘‘signal-independent’’ activation of IL-1b
processing (Agostini et al., 2004). Most components of
the inflammasome (e.g., NALP, ASC-1, caspases, and
others) encode multiple protein-interaction domains
(e.g., PYD, CARD, and NOD/NACT) that promote homo-
typic interactions between molecules that contain simi-
lar domains, forming the scaffold of the inflammasome.
For instance, ASC-1 contains both a PYD and a CARD
and can function as a molecular bridge through its inter-
action with the PYD of various NALP and the CARD of
caspase-1 (see Figure 1 inset).
Unlike most inflammasome components, M13L-PYD
contains a single PYD domain at its N terminus and
can interact with ASC-1 through a PYD-PYD association
(Johnston et al., 2005). This association of M13L-PYD
may disrupt the ability of ASC-1 to form the bridge
between caspases and various NALP, resulting in the
inhibition of caspase-1 activation. A cellular PYD-only-
protein (POP1) that interacts with ASC-1 has been de-
scribed, but POP1 does not appear to arrest IL-1b pro-
duction (Stehlik et al., 2003), suggesting that M13L-PYD
utilizes a distinct mechanism of action from POP1. One
possible model is shown in Figure 1, wherein M13L-PYD
disrupts the formation of a NALP3-containing inflam-
masome through its interaction with ASC-1. However,
several molecularly distinct inflammasomes exist, each
composed of a particular combination of death-fold-
containing adaptor proteins (Martinon and Tschopp,
2004). The exact nature of the inflammasome that is in-
duced by myxoma infection, and consequently inhibited
by M13L-PYD, is currently unknown, but its future iden-
tification will certainly add mechanistic insight to how
M13L-PYD functions to inhibit inflammation.
How does myxoma virus infection activate the inflam-
masome? Although numerous studies have dissected
the molecular aspects of protein-protein interactions
that regulate inflammasome assembly, to date the num-
ber of known physiological ligands/stimuli that catalyze
the assembly are limited. Bacterial muropeptide compo-
nents of peptidoglycans bind directly to the leucine-rich
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554Figure 1. Poxvirus Disruption of the Inflammasome
Myoxma virus (a rabbit poxvirus) encodes a protein, M13L-PYD, that blocks production of interleukin (IL)-1 family cytokines by inhibiting acti-
vation of the cytoplasmic ‘‘inflammasome’’ (Johnston et al., 2005). M13L is composed of an N-terminal pyrin domain (PYD) and a C-terminal do-
main of unknown function, and it interacts with a cellular PYD domain-containing protein (ASC-1) to inhibit inflammasome function. The exact
molecular components of the myxoma-induced inflammasome are not known, and neither is the precise ligand (i.e., trigger) that catalyzes its
formation. For descriptive purposes, a NALP3 (also called cryopyrin, Pypaf1, CIAS1)-containing inflammasome is depicted (see inset box), with
the specific protein domains shown in similar colors. Like domains interact between the various inflammasome components to catalyze assem-
bly. The FIIND domain of Cardinal (also called TUCAN, CARD8, NDDP1) is encoded within NALP1 (Martinon and Tschopp, 2004). CARD, caspase
recruitment domain; LRR, leucine-rich repeat; FIIND, F-interacting domain; NALP, NACHT-LRR-PYD domain-containing protein.repeats (see Figure 1) of NALP3, which resides in the cy-
toplasm, initiating inflammasome assembly/activation
independent of Toll-like receptor signaling (Martinon
et al., 2004). Nuclear factor-kappa B activation through
cytoplasmic recognition of bacterial muropeptides by
members of the NOD family has also been reported (Gir-
ardin et al., 2003). These studies demonstrate that sev-
eral inflammatory pathways are regulated by direct
recognition of pathogen components in the cell cyto-
plasm, the exclusive site of poxviral replication. John-
ston and colleagues demonstrate that infection of a
human monocyte cell line with a mutant myxoma virus
deleted for the PYD domain of M13L was a strong activa-
tor of caspase-1 and of the secretion of IL-1b and IL-18,
as compared to the muted response seen with wild-type
virus (Johnston et al., 2005). These results suggest that
myxoma may contain an as yet uncharacterized ligand
for the inflammasome activation that is suppressed by
M13L-PYD function, although it is also possible that
myxoma infection induces production of a cellular ligand
that activates the inflammasome.
Inaddition to thefunctionthatM13L-PYDplays in inhib-
iting inflammasome activation, the M13L-PYD myxoma
virus mutant replicated very poorly in cultured rabbit lym-
phocytes and monocytes, while replication in fibroblasts
was normal (Johnston et al., 2005). Consistent with this
result, fewer infected cells were found circulating in the
peripheral blood from rabbits infected with the mutant vi-
rus, suggesting that the dissemination of virus wasimpeded. Indeed, decreased numbers of secondary le-
sions in the skin were observed in rabbits infected with
the M13L-PYD mutant. However, the precise reason for
the abortive replication in hematopoietic cells by myx-
oma virus carrying a mutated M13L-PYD is still unclear.
The natural host for myxoma virus is the South Amer-
ican rabbit, Sylvilogus brasiliensis, in which it has effec-
tively adapted to cause a limited, benign infection. How-
ever, when introduced into a foreign host such as the
European rabbit, Oryctolagus cuniculus, myxoma virus
causes a severe, systemic infection, a feature histori-
cally employed as a biological agent for control of Lep-
oridae in Australia (Zuniga, 2002). This (un)intentional
jump to a new host species is a classic example of the
tenuous balance between a pathogen’s virulence fac-
tors and host defense systems. Surprisingly, although
the large DNA genome of myxoma virus harbors a hefty
arsenal of immunomodulating genes, deletion of a single
one such as M13L-PYD attenuates virulence. Indeed,
deletion of one of several other myxoma virus inflam-
matory modulators such as M-T2, the tumor necrosis
factor inhibitor, also limits virulence in the nonadapted
host (Seet et al., 2003). Consequently, the myxoma sys-
tem provides an extremely powerful model for analyz-
ing the contributions of various immune-evasion genes
to the pathogenesis of poxvirus infections and host
responses, recognizing the caveat that not all poxviruses
encode the same immunomodulatory proteins. None-
theless, poxviruses are highly instructive in identifying
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and immune systems, with significant collateral benefit
for other inflammatory diseases. Specifically, this inves-
tigation by Johnston et al. highlights the importance of
a specific target within the inflammasome, the PYD do-
main, and its consequential role in cytokine production
and inflammation.
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